Relaxant effects of vasodilator peptides on isolated basilar arteries from stroke-prone spontaneously hypertensive rats

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 2, 1997, Pages 157-161

  Nishimura, Yoshitaka ^a   Suzuki, Aritomo ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenomedullin; Basilar artery; Calcitonin gene related peptide; Stroke prone spontaneously hypertensive rat; Vasodilator peptide

Indexed keywords

ADRENOMEDULLIN; BRADYKININ; BRAIN NATRIURETIC PEPTIDE; CALCITONIN GENE RELATED PEPTIDE; NEUROKININ A; PEPTIDE HISTIDINE ISOLEUCINE; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BASILAR ARTERY; ENDOTHELIUM; HYPERTENSION; MALE; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

EID: 0030980014     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01800.x     Document Type: Article

References (38)

1. Owman C. Action and interaction of vasoconstrictor peptides and amines in the brain circulation. In: Seylaz J, Sercombe R (eds). Neurotransmission and cerebrovascular function, II. Elsevier Science, Amsterdam. 1989; 243-64.
2. Edvinsson L. Innervation and effects of dilatory neuropeptides on cerebral vessels. New aspects. Blood Vessels 1991; 28: 35-45.
3. Baumbach GL, Heistad DD. Cerebral circulation in chronic arterial hypertension. Hypertension 1988; 12: 89-95.
4. Heistad DD, Baumbach GL. Cerebral vascular changes during chronic hypertension: Good guys and bad guys. J. Hypertens. 1992; 10 (Suppl 7): S71-5.
5. Nishimura Y. Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats. Br. J. Pharmacol. 1996; 117: 1325-33.
6. Nishimura Y, Usui H, Suzuki A, Kajimoto N, Yamanishi Y. Relaxant response of isolated basilar arteries to calcitonin gene-related peptide in stroke-prone spontaneously hypertensive rats. Jpn. J. Pharmacol. 1992; 59: 333-8.
7. Högestätt ED, Andersson K-E, Edvinsson L. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol. Scand. 1983; 117: 49-61.
8. Lee TJ-F, Saito A, Berezin I. Vasoactive intestinal polypeptide-like substance: The potential transmitter for cerebral vasodilation. Science 1984; 224: 898-901.
9. Edvinsson L, Fredholm BB, Hamel E, Jansen I, Verrecchia C. Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci. Lett. 1985; 58: 213-17.
10. Edvinsson L, McCulloch J, Kelly PAT, Tuor UI. Role of vasoactive intestinal peptide and peptide histidine isoleucine in the cerebral circulation. In: Said SI, Mutt V (eds). Vasoactive intestinal peptide and related peptides. New York Academy of Sciences, New York. 1988; 527: 378-92.
11. Suzuki Y, McMaster D, Lederis K, Rorstad OP. Characterization of the relaxant effects of vasoactive intestinal peptide (VIP) and PHI on isolated brain arteries. Brain Res. 1984; 322: 9-16.
12. Edvinsson L, Jansen I. Characterization of tachykinin receptors in isolated basilar arteries of guinea-pig. Br. J. Pharmacol. 1987; 90: 553-9.
13. Mejia JA, Pernow J, Von Holst H, Rudehill A, Lundberg JM. Effects of neuropeptide Y, calcitonin gene-related peptide, substance P, and capsaicin on cerebral arteries in man and animals. J. Neurosurg. 1988; 69: 913-18.
14. Jansen I, Alafaci C, McCulloch J, Uddman R, Edvinsson L. Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: Vasomotor responses in vitro and in situ. J. Cereb. Blood Flow Metab. 1991; 11: 567-75.
15. Hong KW, Pyo KM, Lee WS, Yu SS, Rhim BY. Pharmacological evidence that calcitonin gene-related peptide is implicated in cerebral autoregulation. Am. J. Physiol. 1994; 266: H11-16.
16. Itoh N, Obata K, Yanaihara N, Okamoto H. Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27. Nature 1983; 304: 547-9.
17. Winquist RJ. The relaxant effects of atrial natriuretic factor on vascular smooth muscle. Life Sci. 1985; 37: 1081-7.
18. Wei C-M, Aarhus LL, Miller VM, Burnett JC Jr. Action of C-type natriuretic peptide in isolated canine arteries and veins. Am. J. Physiol. 1993; 264: H71-3.
19. Rosenblum WI. Endothelial dependent relaxation demonstrated in vivo in cerebral arterioles. Stroke 1986; 17: 494-7.
20. Whalley ET, Amure YO, Lye RH. Analysis of the mechanism of action of bradykinin on human basilar artery in vitro. Arch. Pharmacol. 1987; 335: 433-7.
21. Katusic ZS, Marshall JJ, Kontos HA, Vanhoutte PM. Similar responsiveness of smooth muscle of the canine basilar artery to EDRF and nitric oxide. Am. J. Physiol. 1989; 257: H1235-9.
22. Kontos HA, Wei EP, Kukreja RC, Ellis EF, Hess ML. Differences in endothelium-dependent cerebral dilation by bradykinin and acetylcholine. Am. J. Physiol. 1990; 258: H1261-6.
23. Kitamura K, Kangawa K, Kawamoto M et al. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 1993; 192: 553-60.
24. Kitamura K, Kangawa K, Kojima M, Ichiki Y, Matsuo H, Eto T. Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor. FEBS Lett. 1994; 338: 306-10.
25. Nuki C, Kawasaki H, Kitamura K et al. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem. Biophys. Res. Commun. 1993; 196: 245-51.
26. DeWitt BJ, Cheng DY, Caminiti GN et al. Comparison of responses to adrenomedullin and calcitonin gene-related peptide in the pulmonary vascular bed of the cat. Eur. J. Pharmacol. 1994; 257: 303-6.
27. Entzeroth M, Doods HN, Wieland HA, Wienen W. Adrenomedullin mediates vasodilation via CGRP1 receptors. Life Sci. 1994; 56: PL19-25.
28. Baskaya MK, Suzuki Y, Anzai M et al. Effects of adrenomedullin, calcitonin gene-related peptide, and amylin on cerebral circulation in dogs. J. Cereb. Blood Flow Metab. 1995; 15: 827-34.
29. Nakamura K, Toda H, Terasako K et al. Vasodilative effect of adrenomedullin in isolated arteries of the dog. Jpn. J. Pharmacol. 1995; 67: 259-62.
30. Eguchi S, Hirata Y, Kano H et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett. 1994; 340: 226-30.
31. Kapas S, Catt KJ, Clark AJL. Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J. Biol. Chem. 1995; 270: 25344-7.
32. Kato J, Kitamura K, Kangawa K, Eto T. Receptors for adrenomedullin in human vascular endothelial cells. Eur. J. Pharmacol. 1995; 289: 383-5.
33. Chiba T, Yamaguchi A, Yamatani T et al. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J Physiol. 1989; 256: E331-5.
34. 8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J. Pharmacol. Exp. Ther. 1990; 254: 123-8.
35. Xu D, Wang X, Wang J-P et al. Calcitonin gene-related peptide (CGRP) in normotensive and spontaneously hypertensive rats. Peptides 1989; 10: 309-12.
36. Supowit SC, Ramana CV, Westlund KN, DiPette DJ. Calcitonin gene-related peptide gene expression in the spontaneously hypertensive rat. Hypertension 1993; 21: 1010-14.
37. Kawasaki H, Saito A, Takasaki K. Age-related decrease of calcitonin gene-related peptide-containing vasodilator innervation in the mesenteric resistance vessel of the spontaneously hypertensive rat. Circ. Res. 1990; 67: 733-43.
38. Kawasaki H, Takasaki K. Age-related decrease of neurogenic release of calcitonin gene-related peptide from perivascular nerves in spontaneously hypertensive rats. Clin. Exp. Hypertens. 1992; A14: 989-1001.